Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 13, 2024 8:54pm
Global Joint Venture or Partnership
Ronald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” Gilles Gagnon, Chief
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 13, 2024 4:22pm
I asked Perplexity Ai to improve AEZS's news release:
Aeterna Zentaris Completes Pivotal DETECT-Trial for Oral Diagnostic Test Macimorelin, Offering Safer and More Accurate Alternative to Diagnose CGHD Macimorelin demonstrated a favorable safety
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 13, 2024 1:02pm
Perplexity Ai on AEZS's diagnostic for children:
Aeterna Zentaris' diagnostic test for childhood-onset growth hormone deficiency (CGHD) using macimorelin has several potential advantages: Simple oral administration of macimorelin
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 13, 2024 9:10am
New Press Release - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Company expects to report top-line data and complete study results in Q3 2024TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified...
read article.
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 12, 2024 9:30pm
Re proph’s response to the plan
Hey yah, NoShow Ronnie is thrilled, he can still still on his fat backside at home or winter retreat and collect a bigger pay cheque while never showing up. NoShowRonnie is so respected that while at
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 12, 2024 7:47pm
RE:Proph's response to the Plan - BIGGEST PILE OF DODO EVERY
Ronald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” Ronnie Miller, Chairman
...more
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 12, 2024 7:12pm
Proph's response to the Plan - BIGGEST PILE OF DODO EVERY
PROPH WROTE -Gilles is 'The Delivery Man' because he delivers. HAS FAILED TO DELIVER ON EVERYTHING HE HAS PROMISED With absolutely epic timing he acquired AEZS's assets at the bottom of
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 12, 2024 6:18pm
RE:Re:What is the plan!!!
Gilles is 'The Delivery Man' because he delivers. With absolutely epic timing he acquired AEZS's assets at the bottom of the historic biotech bear market for less than cash value. AEZS'
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 12, 2024 2:16pm
RE:What is the plan!!!
These were notes from last AGM to be clear: CZO has shown 2X CoQ10 bioavailability of cyclodextrine and 4X bioavailability of Triolien. Discussions concerning out-licensing a PGX complex are
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 12, 2024 2:15pm
What is the plan!!!
Could much of what we've hear over the past year all come together? I think a first key is the pediatric diagnostic data and a new licensing deal. This will help define how much cash AEZS has to
...more
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Jun 12, 2024 11:53am
RE:Down 13% since merger announced
It is now down to to $9.10 since your post 22% since the annoucement. gagnon HAS TO GO HE IS INCAPABLE OF PROVIDING ANY SHAREHOLDER VALUE. SINCE HE HAS TAKEN CONTROL OF AEZS AND CZO HE HAS NO
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 12, 2024 10:46am
Perplexity Ai on what we can expect from Harvard
Aeterna Zentaris is collaborating with Dr. Michael Levy, a renowned expert in neuromyelitis optica spectrum disorder (NMOSD) from Massachusetts General Hospital, to advance the development of its
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 11, 2024 10:35pm
RE:Advantages of Avenanthramides over NSAIDs
If avenanthramide could treat inflammation and cartilage degradation in osteoarthritis that could be a competitive advantage. In summary, the provided search results indicate that a significant
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 11, 2024 10:16pm
Advantages of Avenanthramides over NSAIDs
Avenanthramides, compounds found in oats, exhibit potent anti-inflammatory properties that may offer advantages over traditional non-steroidal anti-inflammatory drugs (NSAIDs). Here are the key points
...more
(56)
•••
Alex1726
X
View Profile
View Bullboard History
Post by
Alex1726
on Jun 11, 2024 3:33pm
Gagnon again
MILWAUKEE, June 7, 2024 /PRNewswire via COMTEX News Network/ -- AdemiLLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer